LeaderPortfolio
Punia
Vikram Punia
Rank #2050
RUSSIAHealthcarePharmaceuticals

Vikram Punia

Net Worth
$2.03B
0% (24h)
Vikram Punia is a Russian billionaire and the sole owner of Pharmasyntez, a leading pharmaceutical company in Russia. His source of wealth stems from the healthcare industry, specifically from the production of a wide range of medications, including those for tuberculosis, HIV, and cancer. Punia's career began in Russia in 1992, when he arrived in Irkutsk as a student. He founded Pharmasyntez in 1997, which has since become a major player in the Russian pharmaceutical market. As of March 2026, Punia's estimated net worth is $2.0 billion.

The Full Dossier

Early Life

Vikram Singh Punia was born in Jaipur, India, in 1973. He came from a family with a wealthy background. In 1992, at the age of 19, he arrived in Irkutsk, Russia, through a student exchange program, to study medicine.

Rise to Success

Punia started his business journey by reselling goods like tea, leather jackets, and pantyhose. He later transitioned into the pharmaceutical industry, founding Pharmasyntez in 1997 in Irkutsk. The company initially repackaged generic antitubercular medicine imported from India. Over time, Pharmasyntez expanded, establishing multiple factories across Russia and producing a wide array of medicines. In 2008, Punia moved the company's headquarters to Moscow. In 2009, he became a Russian citizen and, in 2010, became the sole owner of Pharmasyntez.

Key Business Strategies

Pharmasyntez focused on producing high-quality, affordable medicines for critical diseases, including tuberculosis, HIV, and cancer. The company also played a role in producing the Sputnik Light coronavirus vaccines during the COVID-19 pandemic. Vikram Punia emphasized import substitution, replacing imported drugs with Russian-made alternatives, and pursued vertical integration, encompassing R&D, manufacturing, and distribution.

Philanthropy

While specific philanthropy amounts are unavailable, Pharmasyntez focuses on providing affordable medicines for critical diseases.

Career Timeline

2024

Order of Friendship

Awarded the Order of Friendship by the President of the Russian Federation

2010

Sole Ownership of Pharmasyntez

Became the sole owner of Pharmasyntez

2009

Became a Russian Citizen

Obtained Russian citizenship

2008

Moved Headquarters to Moscow

Relocated Pharmasyntez's headquarters to Moscow

1997

Founded Pharmasyntez

Established pharmaceutical company in Irkutsk, Russia

Philanthropic Impact

HealthcareN/A

Affordable Medicines

Providing affordable medications for the treatment of diseases like tuberculosis, HIV, and cancer.

Wealth Trajectory